Kineta completed a reverse merger with Yumanity Therapeutics with Kineta, Inc. as the surviving company effective December 19, 2022.
Looking for a particular Yumanity Therapeutics employee's phone or email?
The Yumanity Therapeutics annual revenue was $5.5 million in 2026.
Rich Heyman is the Bod Member of Yumanity Therapeutics.
2 people are employed at Yumanity Therapeutics.
Yumanity Therapeutics is based in Boston, Massachusetts.
The NAICS codes for Yumanity Therapeutics are [541714, 541, 5417, 54171, 54].
The SIC codes for Yumanity Therapeutics are [873, 87].